Dilution profile // every instrument, one screen, from SEC filings

Polaryx Therapeutics, Inc. (PLYX)

CIK 2075320 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$483M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
registered capacity, not remaining: amounts already taken down are not subtracted yet
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW0% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
MEDIUM~9.4 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2026-02-012026-05-01

Latest: 47.3M shares as of May 1, 2026 (10-Q).

Cash runway

~9 months of cash left

burning $986,000 / quarter

Full breakdown: cash runway tool · source filing →

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

No convertible-note facts tagged in the 10-Q filed May 15, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $482.6Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-1Nov 21, 2025$482.6M registeredfiling →

Last 12 months: 2 executed · 3 registered.

EXECUTEDMay 28, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDFeb 2, 2026Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4
EFFECTIVEJan 29, 2026SEC declared a registration effective — selling can beginEFFECT
REGISTEREDJan 27, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A
REGISTEREDJan 14, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A
REGISTEREDNov 21, 2025S-1 registration — capacity to sell shares, not a sale yetS-1

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full PLYX workspace